Influenza virus infection
(Influenza viruses A, B, incl. H5N1 family of orthomyxoviruses)
Material: | Antibody-demonstration: 1 ml serum PCR: Pharyngeal- or nasopharyngeal swab (dry), 1 ml bronchial secretion, 1 ml BAL, 1 ml tracheal secretion, 1 ml nasopharyngeal aspirate, 1 ml sputum |
Methods: |
Ligandenassays → Enzyme Linked Immunosorbent Assay (ELISA) Amplifikationsverfahren → Real-time-PCR | Criteria for evaluation | IgG: < 16 RE/ml – 21 RE/ml |
Indication | Fever, headaches, pneumonia, aching limbs, rarely meningoencephalitis | Mandatory reporting | ja The laboratory must only report direct pathogen detection by name to the health department. |
Please note | Incubation period is 2 – 6 days. Infection of the upper airways, pneumonia generally as bacterial superinfection. Influenza A viruses as the cause of pandemics through the development of constantly new antigen-variants, influenza B viruses rather localized with relatively constant antigen behavior, influenza C viruses very rarely in adolescents.
Diagnostics of choice is the molecular-biological direct demonstration from swab material by PCR. Serology is often not very meaningful, especially since there are cross-reactions to the parainfluenza virus. |
Accredited | ja |
More Results for the letter I
- Interleukin-6 (INLEU6)
- Intrinsic factor autoantibodies (INTFA)
- Iodine (JOD)
- Iron (FE)
- FE
- Iron binding capacity (EBK)
- IBC
- Islet-cell autoantibodies (ICA)
- CA, pancreatic islet-cell antibodies
- Isospora belli (ISOBELLI)
- Coccidia
- Itraconazole (ITRA)